Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-23

Clinical Trial Update: Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial sponsored by Merck Sharp & Dohme LLC investigating pediatric patients with documented Candida (Candidiasis) or Aspergillus in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Aspergillosis, Candidiasis | Phase 2 | Status: COMPLETED